MedTrace Logo

EMS-Initiated Buprenorphine

NCT07475728 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 495

Last updated 2026-03-16

No results posted yet for this study

Summary

This is a multisite EMS study that will first conduct a sequence of pragmatic, prehospital field studies to provide preliminary feasibility, acceptability, and safety data for refinement and enhancement of a subsequent single-arm prospective trial that will provide preliminary effectiveness data, from which to build a larger randomized control trail (RCT) trial.

Conditions

Sponsors & Collaborators

  • National Drug Abuse Treatment Clinical Trials Network

    collaborator NETWORK

  • The Emmes Company, LLC

    collaborator INDUSTRY

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Gail D'Onofrio, MD, MS · Yale University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-31
Primary Completion
2029-03-31
Completion
2029-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07475728 on ClinicalTrials.gov